ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
UCB NPV (PK)

UCB NPV (PK) (UCBJF)

195.25
5.25
( 2.76% )
Updated: 01:31:27

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
195.25
Bid
194.25
Offer
202.00
Volume
100
195.25 Day's Range 195.25
100.00 52 Week Range 200.00
Market Cap
Previous Close
190.00
Open
195.25
Last Trade
100
@
195.25
Last Trade Time
01:31:27
Financial Volume
US$ 19,525
VWAP
195.25
Average Volume (3m)
181
Shares Outstanding
189,594,898
Dividend Yield
-
PE Ratio
105.44
Earnings Per Share (EPS)
1.81
Revenue
4.87B
Net Profit
343M

About UCB NPV (PK)

UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector
Pharmaceutical Preparations
Industry
Chemicals & Allied Products
Website
Headquarters
Brussels, Brussels-capital Region, Bel
Founded
1928
UCB NPV (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker UCBJF. The last closing price for UCB NPV (PK) was US$190. Over the last year, UCB NPV (PK) shares have traded in a share price range of US$ 100.00 to US$ 200.00.

UCB NPV (PK) currently has 189,594,898 shares in issue. The market capitalisation of UCB NPV (PK) is US$36.02 billion. UCB NPV (PK) has a price to earnings ratio (PE ratio) of 105.44.

UCBJF Latest News

Bristol Myers Deal Overshadows Q4 loss at Five Prime - Analyst Blog

Five Prime Therapeutics, Inc. (FPRX) has been in the news over the past few days. Investors at Five Prime, which went public in September last year, had plenty to cheer when the company inked a...

Data on UCB's Neupro - Analyst Blog

UCB (UCBJF) recently presented data from a study showing the effect of Neupro on cardiovascular measures in patients with restless legs syndrome (RLS). The double-blind, placebo-controlled...

Nektar Posts Wider Loss, Maintains View - Analyst Blog

Nektar Therapeutics (NKTR) reported a loss of 48 cents per share in the first quarter of 2013, wider than the year-ago loss of 34 cents and the Zacks Consensus Estimate of a loss of 41 cents...

Questcor Misses on Earnings, Revs - Analyst Blog

Questcor Pharmaceuticals Inc. (QCOR) reported first quarter 2013 adjusted earnings per share of 67 cents, up 15.5% from the year-ago period. Earnings were, however, well below the Zacks...

Valeant Beats Earnings, Misses Revs - Analyst Blog

Valeant Pharmaceuticals’ (VRX) first quarter 2013 earnings of $1.27 (excluding special items but including stock-based compensation expense) were short of the Zacks Consensus Estimate by a...

Shire Beats Earnings in 1Q - Analyst Blog

Shire’s (SHPG) first quarter 2013 earnings (excluding special items) of 1.63 as per American Depositary Share (ADS) beats the Zacks Consensus Estimate of $1.61. The reported...

Glaxo's Trametinib Delayed - Analyst Blog

Recently, GlaxoSmithKline (GSK) announced that the US Food and Drug Administration (FDA) has extended the review period for Glaxo’s oncology candidate, trametinib, by three months. A final...

ViroPharma Reports Loss in 1Q - Analyst Blog

ViroPharma Inc.’s ( VPHM ) first quarter 2013 adjusted loss (excluding special items but including stock-based compensation) came in at 7 cents per share compared to year-ago earnings...

Actavis Beats on Earnings, Raises View - Analyst Blog

Actavis, Inc.’s (ACT) first quarter 2013 earnings of $1.99 per share beat the Zacks Consensus Estimate of $1.87 and increased 21% from the year-ago earnings. Revenues for the reported...

Loss Widens at Momenta - Analyst Blog

Momenta Pharmaceuticals Inc. (MNTA) reported first quarter 2013 net loss per share of 48 cents, wider than the Zacks Consensus Estimate of a loss of 43 cents and the year-ago loss of 10...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000195.25000CS
4-4.75-2.37520020019091193.44014733CS
120.490.251591702608194.76200174181189.32837737CS
2642.7528.0327868852152.5200152.5189182.56500707CS
5295.2595.25100200100252147.18621915CS
15694.928194.6235069312100.321920068.30106264694.30342003CS
26099.4103.70370370495.8520067.3984694.65387712CS

UCBJF - Frequently Asked Questions (FAQ)

What is the current UCB NPV (PK) share price?
The current share price of UCB NPV (PK) is US$ 195.25
How many UCB NPV (PK) shares are in issue?
UCB NPV (PK) has 189,594,898 shares in issue
What is the market cap of UCB NPV (PK)?
The market capitalisation of UCB NPV (PK) is USD 36.02B
What is the 1 year trading range for UCB NPV (PK) share price?
UCB NPV (PK) has traded in the range of US$ 100.00 to US$ 200.00 during the past year
What is the PE ratio of UCB NPV (PK)?
The price to earnings ratio of UCB NPV (PK) is 105.44
What is the cash to sales ratio of UCB NPV (PK)?
The cash to sales ratio of UCB NPV (PK) is 7.43
What is the reporting currency for UCB NPV (PK)?
UCB NPV (PK) reports financial results in EUR
What is the latest annual turnover for UCB NPV (PK)?
The latest annual turnover of UCB NPV (PK) is EUR 4.87B
What is the latest annual profit for UCB NPV (PK)?
The latest annual profit of UCB NPV (PK) is EUR 343M
What is the registered address of UCB NPV (PK)?
The registered address for UCB NPV (PK) is 60, ALLEE DE LA RECHERCHE, BRUSSELS, BRUSSELS-CAPITAL REGION, B-1070
What is the UCB NPV (PK) website address?
The website address for UCB NPV (PK) is www.ucb.com
Which industry sector does UCB NPV (PK) operate in?
UCB NPV (PK) operates in the CHEMICALS & ALLIED PRODUCTS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HOMUHoumu Holdings Ltd (CE)
US$ 0.0025
(249,900.00%)
18.05k
SIRCSolar Integrated Roofing Corporation (PK)
US$ 0.0001
(9,900.00%)
424.68k
JAMNJammin Java Corp (PK)
US$ 0.0001
(9,900.00%)
196k
BRGOBergio International Inc (PK)
US$ 0.0001
(9,900.00%)
501.75k
PSRUValiant Eagle Inc (PK)
US$ 0.0001
(9,900.00%)
7.04M
PXMDPaxMedica Inc (CE)
US$ 0.000001
(-100.00%)
2.8k
GTIIGlobal Tech Industries Group Inc (CE)
US$ 0.0001
(-99.75%)
9.74k
PKLBFPerk Labs Inc (CE)
US$ 0.000001
(-99.67%)
20k
FBCDFBC Holding Inc (PK)
US$ 0.000001
(-99.00%)
50k
CCGYChina Clean Energy Inc (CE)
US$ 0.000001
(-99.00%)
102k
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0002
(100.00%)
149.47M
RONNRonn Motor Group Inc (PK)
US$ 0.0003
(0.00%)
99.53M
HMBLHUMBL Inc (PK)
US$ 0.0007
(-12.50%)
85.94M
SPRVSupurva Healthcare Group Inc (PK)
US$ 0.0001
(0.00%)
62.88M
HCMCHealthier Choices Management Corporation (PK)
US$ 0.000001
(0.00%)
27.86M

Discussion

View Full Feed
Budots Budots 2 minutes ago
$XONI Xtreme Fighting Championships Relaunches Young Guns Series at Kill Cliff Fight Club Live on January 29th, 2025 https://finance.yahoo.com/news/xtreme-fighting-championships-relaunches-young-142700259.html
XONI
PTiHubber PTiHubber 2 minutes ago
All Time High
COOP
lakers17 lakers17 2 minutes ago
Again with the 2021 nonsense? Sorry not happening as it didn't in 2024 as you clamed hundreds of times. Pushing low price OTC diluted garbage didn't work in 2024 and won't in 2025. Soon we'll be hearing how OTC 2026 will be like 2021. That was a unique OTC never to happen again for many reasons.
PDGO
CAN11 CAN11 2 minutes ago
What was the O/S January 2023 vs January 2025. Billions more. And endless BS PR announcements resulting in .0001. Absolutely no value add to share holders.
PSRU
Budots Budots 2 minutes ago
$XONI Xtreme Fighting Championships Relaunches Young Guns Series at Kill Cliff Fight Club Live on January 29th, 2025 https://finance.yahoo.com/news/xtreme-fighting-championships-relaunches-young-142700259.html
XONI
Donotunderstand Donotunderstand 3 minutes ago
interesting !!!
not sure if that is really part of their mission but interesting
thank you
FNMA
payupdeadbeat payupdeadbeat 3 minutes ago
The Ranch was never owned by this small time looser. He only played a slithering role in the LVVV shell game. He is a skunk.
LVVV
TrendTrade2016 TrendTrade2016 3 minutes ago
Top in
ICAD
surfkast surfkast 3 minutes ago
Pathetic is today's word.
IGPK
fung_derf fung_derf 3 minutes ago
What fate is that???
I've only been here for 25 years.
You mean the fate where I come back to this board a year from now and nothing has changed, including your whining?
A weak human mind will show the inability to once, an notion is formed, to ever adjust it. It's the secret t
GDVM
manysevens manysevens 3 minutes ago
GCTK nice lil rally this morning :-)
GCTK
Brodey79 Brodey79 3 minutes ago
Nice score congrats.
FDCT
DrHigh DrHigh 3 minutes ago
White House and DOJ are for sale. If you think KG cannot buy his way out of any criminal proceedings, I have a bridge to sell you. This stock is owned by retail morons like myself. We have no representation. If this were actually owned by respected financial institutions then we might have a leg to
NWBO
Donotunderstand Donotunderstand 4 minutes ago
as often - I find such articles lacking

what does privatization mean (or release) ?
Who then owns Fannie --- us current owners at 100% or 50% or 20% or 1 %
Why is there an assumption there is not GOV backup ? --- Why can the GOV not sit in second place - as guarante
FNMA
PatB1 PatB1 4 minutes ago
Whoa, baby. Look at this puppy move! Should be millionaires any year now. Garbage.....if everything these pumpers are saying were true, we'd have seen some movement by now.  Something is just not right here!
ASII
Calvin Hobbes Calvin Hobbes 4 minutes ago
$GGSM NO scam, Do your DD instead of BS fud here.
GGSM
learningcurve2020 learningcurve2020 4 minutes ago
They use 7%. Private company with properly staffed management team.

“ Announces Completion of $29 Million Financing and Confirms Timing for Topline Results of Phase 2b Trial of IGV-001 in Newly Diagnosed Glioblastoma”

https://www.biospace.com/press-releases/imvax-annou
NWBO
JALEB JALEB 4 minutes ago
Picked up 3-4 Mils from the 5s
ASII
jackson73 jackson73 4 minutes ago
SGN 7.00+ hit, thx bud yours are appreciated as well ;-)
SGN
linkvest linkvest 4 minutes ago
More than half was me accumulating lol..... we are not going to see these freakin low stock prices to much longer so I'm taking advantage of the weak hands that are selling out.
ASII
LessIsMore LessIsMore 4 minutes ago
I have steadily accumulated over the years and really bought big between $.17 and $.22 after the double bottom was called on this board

We must've been buying on the same days, I was able to get 450 Million shares at an average of 17.5 cents. This fake trading can be really fun can't
NWBO
ANTI-BAGHOLDER ANTI-BAGHOLDER 4 minutes ago
TPIA News.  5 million floater worth a look:
TPIA
Invest-in-America Invest-in-America 4 minutes ago
SGN: Ten bucks easy!!! 600%-to-700% runner!! (Thanks for tip!!)
SGN
vlispxpert vlispxpert 4 minutes ago
M N M D 67% inst, 73.3 mill o/s, 10.43 mill short....oh boy, ingredients for a short squeeze imo

Your Recent History

Delayed Upgrade Clock